(Q44300088)

1 December 2017

Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen (English)

1 reference

1 December 2017

1 reference

10

Graham R V Hughes

1 reference

1 December 2017

9

Munther A Khamashta

1 reference

1 December 2017

13

Eiji Matsuura

1 reference

1 December 2017

11

Takao Koike

1 reference

1 December 2017

Maria Laura Bertolaccini

4

object named as

Maria L Bertolaccini

1 reference

1 December 2017

3

Tatsuya Atsumi

1 reference

1 December 2017

Kazuko Kobayashi

1

1 reference

1 December 2017

Makoto Kishi

2

1 reference

1 December 2017

Hirofumi Makino

5

1 reference

1 December 2017

Nobuo Sakairi

6

1 reference

1 December 2017

Itaru Yamamoto

7

1 reference

1 December 2017

Tatsuji Yasuda

8

1 reference

1 December 2017

Dennis R Voelker

12

1 reference

1 December 2017

16 January 2003

1 reference

Journal of Lipid Research

1 December 2017

1 reference

1 December 2017

44

1 reference

1 December 2017

716-726

1 reference

1 December 2017

4

1 reference

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

1 December 2017

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Low density lipoprotein oxidation and its pathobiological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Biologically active oxidized phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Low density lipoprotein undergoes oxidative modification in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol condensation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Identification of the phospholipid-binding site of human beta(2)-glycoprotein I domain V by heteronuclear magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Flexible loop of beta 2-glycoprotein I domain V specifically interacts with hydrophobic ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Omega-carboxyl variants of 7-ketocholesteryl esters are ligands for beta(2)-glycoprotein I and mediate antibody-dependent uptake of oxidized LDL by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Anticardiolipin antibodies from patients with the antiphospholipid antibody syndrome recognize epitopes in both beta(2)-glycoprotein 1 and oxidized low-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Anti-modified LDL antibodies and LDL-containing immune complexes in IDDM patients and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

beta 2-Glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Conformationally altered beta 2-glycoprotein I is the antigen for anti-cardiolipin autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Dimers of beta 2-glycoprotein I mimic the in vitro effects of beta 2-glycoprotein I-anti-beta 2-glycoprotein I antibody complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Lack of cross-reaction between antibodies to beta2-glycoprotein-I and oxidized low-density lipoprotein in patients with antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Involvement of beta 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

beta 2-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Proteolytic cleavage of beta(2)-glycoprotein I: reduction of antigenicity and the structural relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

A method for defining the stages of low-density lipoprotein oxidation by the separation of cholesterol- and cholesteryl ester-oxidation products using HPLC

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Isolation of soluble immune complexes from human serum: combined use of polyethylene glycol precipitation, gel filtration, and affinity chromatography on protein A-Sepharose

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200329-JLR200

10.1194/JLR.M200329-JLR200

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference